HK inno.N Corporation
KOE: 195940.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Dal-Won Kwak
- Employees
- 1,694
- Headquarters
- Cheongju-si, South Korea
- IPO year
- 2021
- Market cap
- ₩1.4T
- Website
- https://www.inno-n.com
Loading 195940…
Loading profile data…Frequently asked questions about 195940
What does HK inno.N Corporation (195940.KQ) do?
HK inno.N Corporation engages in the pharmaceutical business in South Korea. The company offers prescription drugs for the treatment of gram-positive and gram-negative organisms, enterococcus faecium infections, vancomycin-resistant, acute bacterial sinusitis, bronchitis, neumonia, antibiotics, and infections caused by microorganism; anemia and...
Where does 195940.KQ trade?
HK inno.N Corporation (195940.KQ) trades on the KOSDAQ.
What sector is 195940.KQ in?
HK inno.N Corporation (195940.KQ) operates in the Healthcare sector, specifically in the Medical - Care Facilities industry.
Who is the CEO of HK inno.N Corporation?
Dal-Won Kwak is the chief executive officer of HK inno.N Corporation (195940.KQ).
Where is HK inno.N Corporation headquartered?
HK inno.N Corporation is headquartered in South Korea.
Does 195940.KQ pay a dividend?
Yes — HK inno.N Corporation (195940.KQ) paid a trailing twelve-month dividend of KRW 410.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 195940.KQ go public?
HK inno.N Corporation (195940.KQ) completed its initial public offering in 2021.